Health Lab
In cell-line and mouse models of ovarian cancer, researchers developed an interdisciplinary approach to identify metabolic vulnerabilities in certain genes that could be targeted to kill cancer cells.
Health Lab
A clearer picture of how a cell is organized could help biologists learn how to reprogram a cell to halt cancer or other diseases.
Health Lab
Biopsies from the same patients before and after treatment reveal how a specific drug reprograms prostate tumors.
Health Lab
A clinical trial in head and neck cancer explored ways to improve clinical outcomes for patients. Although the trial failed, researchers found insight into new ways to address treatment resistance.
Health Lab
GOT2 causes metabolic changes that pancreas tumors overcome.
Health Lab
Breakthroughs in the field of genomics are revolutionizing prevention, diagnosis and care.
Health Lab
Patients with relapsed multiple myeloma are resistant to commonly used treatments. Researchers are one step closer to understanding the genetic reason why.
Health Lab
Leah Koskinen shares her experience of being a new mom while managing the stresses of diagnosis, treatment and recovery from skin cancer.
Health Lab
In mice, researchers have discovered the presence of oncostreams, highly active cells connected to how brain tumors grow and invade healthy tissue.
Health Lab
The findings could help shorten hospital stays for cancer patients.
Health Lab
A study suggests substances touted to improve athletic performance can activate a receptor that accelerates the progression of pre-cancerous lesions to pancreatic cancer in mice.
Health Lab
Steve Keating will likely die from his end-stage colon cancer. But he’s using whatever time he has left to share his knowledge of the cancer experience with other patients.
Health Lab
Men with advanced prostate cancer taking abiraterone or enzalutamide plus hormone therapy were at higher risk of serious medical issues than their peers undergoing hormone therapy alone.
Health Lab
Eighty percent of patients with a subset of lymphoma saw their cancers shrink after taking zanubrutinib in a clinical trial.
Health Lab
In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cancer.